CLINICAL_TRIALS
trial_result
· 2026-01-29
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis [Phase 2, Phase 3]
Summary
A completed Phase 2/3 study evaluating the efficacy and safety of ABC008 for inclusion body myositis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abcuro, Inc. | Conditions: Inclusion Body Myositis | Phase 2, Phase 3 | Status: COMPLETED